Cargando…

SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXRα/FOXM1 pathway independently of REV-ERBs

Perturbations of the circadian clock are linked to multiple diseases, including cancers. Pharmacological activation of REV-ERB nuclear receptors, the core components of the circadian clock, has antitumor effects on various malignancies, while the impact of SR9009 on prostate cancer (PCa) remains unk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Hang, Zhang, Jiapeng, Zheng, Xiaonan, Tan, Ping, Xiong, Xingyu, Yi, Xianyanling, Yang, Yang, Wang, Yan, Liao, Dazhou, Li, Hong, Wei, Qiang, Ai, Jianzhong, Yang, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649669/ https://www.ncbi.nlm.nih.gov/pubmed/36357378 http://dx.doi.org/10.1038/s41419-022-05392-6

Ejemplares similares

In Vitro Metabolic Studies of REV-ERB Agonists SR9009 and SR9011
por: Geldof, Lore, et al.
Publicado: (2016)

REV-ERBα Agonist SR9009 Promotes a Negative Energy Balance in Goldfish
por: Saiz, Nuria, et al.
Publicado: (2022)

SR9009 improves heart function after pressure overload independent of cardiac REV-ERB
por: Li, Hui, et al.
Publicado: (2022)

Chemotherapeutic Effect of SR9009, a REV-ERB Agonist, on the Human Glioblastoma T98G Cells
por: Wagner, Paula M., et al.
Publicado: (2019)

SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy
por: Shen, Weitao, et al.
Publicado: (2020)

Rev-erbα agonist SR9009 protects against cerebral ischemic injury through mechanisms involving Nrf2 pathway
por: Sheng, Mingyue, et al.
Publicado: (2023)

The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock
por: Ishimaru, Kayoko, et al.
Publicado: (2019)

Circadian Clock REV-ERBs Agonist SR9009 Induces Synergistic Antitumor Activity in Multiple Myeloma by Suppressing Glucose-Regulated Protein 78-Dependent Autophagy and Lipogenesis
por: Wang, Rui, et al.
Publicado: (2023)

SR9009 Regulates Acute Lung Injury in Mice Induced by Sepsis
por: Hu, Ming, et al.
Publicado: (2022)

Pharmacological activation of REV-ERBs is lethal in cancer and oncogene induced senescence
por: Sulli, Gabriele, et al.
Publicado: (2018)

Regulation of Circadian Behavior and Metabolism by Rev-erbα and Rev-erbβ
por: Cho, Han, et al.
Publicado: (2012)

Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence
por: Gao, Li‐Bin, et al.
Publicado: (2021)

The Effect of Rev-erbα Agonist SR9011 on the Immune Response and Cell Metabolism of Microglia
por: Wolff, Samantha E. C., et al.
Publicado: (2020)

REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output
por: Ikeda, Ryosuke, et al.
Publicado: (2019)

Distinct roles for REV-ERBα and REV-ERBβ in oxidative capacity and mitochondrial biogenesis in skeletal muscle
por: Amador, Ariadna, et al.
Publicado: (2018)

Direct Regulation of CLOCK Expression by REV-ERB
por: Crumbley, Christine, et al.
Publicado: (2011)

Rev-erbs and Glia—Implications for Neurodegenerative Diseases
por: Griffin, Percy, et al.
Publicado: (2019)

REV-ERB is essential in cardiac fibroblasts homeostasis
por: Luo, Xiaokang, et al.
Publicado: (2022)

The Role of REV-ERB Receptors in Cancer Pathogenesis
por: Gomatou, Georgia, et al.
Publicado: (2023)

Vitamin E intake and multiple health outcomes: an umbrella review
por: Zhang, Tianyi, et al.
Publicado: (2023)

Decreased expression of Rev-Erbα in the epileptic foci of temporal lobe epilepsy and activation of Rev-Erbα have anti-inflammatory and neuroprotective effects in the pilocarpine model
por: Yue, Jiong, et al.
Publicado: (2020)

SR9009 administered for one day after myocardial ischemia-reperfusion prevents heart failure in mice by targeting the cardiac inflammasome
por: Reitz, Cristine J., et al.
Publicado: (2019)

Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replication
por: Borrmann, Helene, et al.
Publicado: (2020)

Translational Regulation of Clock Genes BMAL1 and REV-ERBα by Polyamines
por: Sakamoto, Akihiko, et al.
Publicado: (2021)

Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation
por: Amador, Ariadna, et al.
Publicado: (2016)

Expression of AFP and Rev-Erb A/Rev-Erb B and N-CoR in fetal rat liver, liver injury and liver regeneration
por: Meier, Volker, et al.
Publicado: (2006)

Comparison of the Efficacy and Safety of Extracorporeal Shock Wave Lithotripsy and Flexible Ureteroscopy for Treatment of Urolithiasis in Horseshoe Kidney Patients: A Systematic Review and Meta-Analysis
por: Yi, Xianyanling, et al.
Publicado: (2021)

Rev-erb in GABAergic Neurons Controls Diurnal Hepatic Insulin Sensitivity
por: Ding, Guolian, et al.
Publicado: (2021)

The circadian clock components BMAL1 and REV-ERBα regulate flavivirus replication
por: Zhuang, Xiaodong, et al.
Publicado: (2019)

Regulation of Circadian Behavior and Metabolism by Synthetic REV-ERB Agonists
por: Solt, Laura A., et al.
Publicado: (2012)

Novel Function of Rev-erbα in Promoting Brown Adipogenesis
por: Nam, Deokhwa, et al.
Publicado: (2015)

Rev-erbα in the brain is essential for circadian food entrainment
por: Delezie, Julien, et al.
Publicado: (2016)

Targeting REV-ERBα for therapeutic purposes: promises and challenges
por: Wang, Shuai, et al.
Publicado: (2020)

Downregulation of REV-ERBα is associated with the progression of lung adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2022)

Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid Tumors
por: Nguyen, Trang Thi Thu, et al.
Publicado: (2019)

Dendrogenin A drives LXR to trigger lethal autophagy in cancers
por: Segala, Gregory, et al.
Publicado: (2017)

Pharmacological Rescue with SR8278, a Circadian Nuclear Receptor REV-ERBα Antagonist as a Therapy for Mood Disorders in Parkinson’s Disease
por: Kim, Jeongah, et al.
Publicado: (2022)

High Amplitude Phase Resetting in Rev-Erbα/Per1 Double Mutant Mice
por: Jud, Corinne, et al.
Publicado: (2010)

The Nuclear Receptor Rev-erbα Controls Circadian Thermogenic Plasticity
por: Gerhart-Hines, Zachary, et al.
Publicado: (2013)

REV-ERBα influences the stability and nuclear localization of the glucocorticoid receptor
por: Okabe, Takashi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vdnmlj5sglmvakdferql76frkt